Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)

NCT05600556 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-05-15

No results posted yet for this study

Summary

This clinical trial explores if using virtual reality (VR) headsets will help to improve patient understanding of their disease and decrease anxiety about treatment. Three-dimensional (3D) images may help the patient visualize their tumor and location better and therefore understand potential side effects. Visualizing a virtual representation of the magnetic resonance imaging (MRI) linear accelerator (Linac) may decrease treatment related anxiety.

Conditions

  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm

Interventions

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Computed Tomography

Undergo CT

OTHER

Best Practice

Review imaging on standard computer screen

OTHER

Questionnaire Administration

Complete questionnaire

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Computed Tomography

Undergo CT

OTHER

Virtual Technology Intervention

Review virtual reality images

OTHER

Questionnaire Administration

Complete questionnaire

Sponsors & Collaborators

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Adam Mueller, MD · Thomas Jefferson University

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-01-01
Completion
2025-02-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05600556 on ClinicalTrials.gov